Stocktwits Top 25 – Week 25 ๐Ÿ“ˆ

Good evening, everyone. Welcome to the Stocktwits Top 25 Newsletter for Week 25 in 2021.

The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD), and tracks their performances over time. 

Here are your Stocktwits Top 25 Lists for Week 25:

ST Top 25 S&P 500

The ST Top 25 S&P 500 list stormed back in Week 25. 

24 of 25 names closed positive.

Oil stocks continued to trend higher. ๐Ÿ“ˆ 6 of the top-10 names are energy companies.

$OXY ascended 17.6% and gained three spots to #4. The energy company was the listโ€™s biggest gainer, you can find it on the Winners list below. 

4 Freshmen debuted on the list. They include; $WFC, $DXC, $MPC, and $OKE.

The Stocktwits Top 25 S&P 500 Momentum Meter gained 7.86% while the S&P 500 gained 2.74%. The 5.12% differential in favor of the top-25 shows the top stocks outperformed the full index by a large amount.

The Big Cap Nasdaq 100

The ST Top 25 N100 put another strong week on the board. 24/25 names closed green, nearly perfect. โœ…

eBay made the listโ€™s biggest move, easing 7.3% higher. $EBAY improved 3 spots from #9 to #6 and is a Winner below. 

$BIIB, the biggest loser, busting 10.4% and falling three spots from #1 to #4.๐Ÿ“‰ Check it out below. 

Two Freshmen made the list. They are Ulta Beauty and Liberty Global.

The ST Top 25 Nasdaq 100 Momentum Meter moved up 3% in Week 25 while the full Nasdaq 100 climbed 2.1%. The 0.9% difference shows the top stocks were a tad bit stronger than the full index.

Small-Cap Russell 2000

The ST Top 25 R2K List showed weakness near the top of the leaderboard but rallied higher nonetheless. 

20 of 25 names closed higher.

Express Inc exploded 56% and remains in the top-five at #4. $EXPR is the Top Dawg below. ๐Ÿ‘‘

$DDD ripped 40.6%, $CHS climbed 36.4%, and $SM soared 27.5%.

4 new stocks appeared on the ST Top 25 Russell 2000 list. The names include $PRTA, $RUBY, $PAVM, and $MTDR.

The ST Top 25 R2K Momentum Meter increased 11.06% while the Russell 2000 index gained 4.32%. The 6.74% differential shows the top stocks are stronger than the full index by a wide margin.


The ST Top 25 Top Dawg for Week 25, 2021 is #4 R2K – Express Inc.

Express Inc erupted 56% in Week 25 after the retail company became one of the latest MemeStocks targeted by retail traders. ๐ŸŒ‹

$EXPR accelerated from $4.58 on Monday and closed above $7 on Friday. Hereโ€™s the YTD daily chart:

$EXPR has risen 680% YTD and three-year highs are on deck next. Weโ€™ll see if this one can reach a 1,000% return by the end of 2021.

The Winners ๐Ÿ“ˆ

โ–ณ #4 S&P 500 – Occidental Petroleum Corp rose 17.6% in Week 25 and improved three spots from #7  to #4.

$OXY got straight to business Monday, gaining 5.4%. The energy company traded higher in the days following as crude oil closed at ~ 3-year highs. ๐Ÿ›ข

Still, $OXY trails fellow energy companies $MRO and $FANG in the #1 and #2 rankings.

$OXY is up 9% YTD.

โ–ณ #6 N100 – eBay. Donโ€™t sleep on it. ๐Ÿ‘€ The e-commerce  company eased 7.3% higher to all-time highs. Itโ€™s now ranked ninth.

$EBAY made back all of week 24โ€™s losses and then some. It accomplished this by closing green 5/5 days.

Hereโ€™s the weekly chart:

$EBAY is up 35% YTD. 

โ–ณ #10 R2K – 3 D Systems printed itself a 40% gain and improved nine spots on the ST Top 25 R2K List.  

On Tuesday, 3 D systems and CollPlant Biotechnologies announced a co-development agreement for a 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant. โค๏ธ โ›‘

$DDD spiked 28% in response to the news.

Dr. Jeffrey Graves, CEO of 3D Systems said:

Through this project weโ€™re embarking on with CollPlant, weโ€™re exploring a novel application that could offer a new reconstruction treatment for breast cancer survivors. Itโ€™s inspiring to be involved in a project that has the potential to have such a positive impact on the human condition.

$DDD is up 275% YTD.

The Sinners ๐Ÿ“‰

โ–ผ #25 S&P 500 – Iron Mountain Inc slid down the mountain this week. ๐Ÿ”๐Ÿ“‰ The information storage and management REIT fell 2.5% and was the only name to close red on the ST Top 25 S&P 500 List. 

On Thursday Iron Mountain revealed that it had sold a portfolio of five facilities to Intermediate Capital Group (ICG), generating a tidy profit of $178 million.

The 550,000-square-foot transaction is a sale-leaseback arrangement including assets in the greater London area. Iron Mountain will stay in these premises for a minimum of twelve years, with the option to extend the lease for up to another 20 years. 

This transaction is part of Iron Mountain’s continuous capital recycling program, and the funds will be used to reinvest in the company’s higher-growth areas.

Barry Hytinen, CFO at Iron Mountain commented: 

The sale-leaseback of these assets allows us to generate significant investable proceeds while essentially maintaining long-term control of the facilities. On a leverage neutral basis, we estimate this transaction will generate nearly $140 million of capital, which we intend to invest in higher growth areas, including our data center business. 

$IRM is up 46% YTD.

โ–ผ #4 N100 – Biogen didn’t have what it took to remain in the top spot on the ST Top 25 N100 List. $BIIB was the biggest loser on the list, dropping 10.4%.

$BIIB traded lower every single day this week including a 6% gap down on Thursday.

The FDA designated Eli Lilly and Companyโ€™s experimental Alzheimer’s medicine, donanemab, for accelerated clearance procedure on Thursday. The FDA’s decision follows the agency’s approval of Biogen’s Aduhelm, the first Alzheimer’s medication approved in two decades. 

Many analysts project that donanemab can be approved and  become a multibillion-dollar seller by the middle of next year. ๐Ÿคท 

$BIIB fell 6.1% on fears that its newly authorized Alzheimer’s medication might face fierce competition sooner than planned. Both Aduhelm and donanemab are drugs that target amyloid, a sticky material found in the brain that is linked to Alzheimer’s disease.

$BIIB is still up 42% YTD.

See Yโ€™all Next Week ๐Ÿค™